Strides Pharma Testosterone Gel Recalled Due to Benzene Contamination
Strides Pharma is recalling Testosterone Gel 1% (195,952 cartons nationwide) due to benzene contamination. Consumers using affected lots should immediately contact their healthcare provider.
What this means for you
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: FDA Class II recall with benzene contamination, a known carcinogenic hazard. Although no illnesses or injuries have been reported, the presence of benzene in a transdermal product presents significant potential for harm.
Plain-English summary
Strides Pharma, Inc. is recalling Testosterone Gel 1%, a prescription medication sold in 2.5-gram unit-dose packets. The product was distributed nationwide in the United States.
The recall was initiated due to the presence of benzene, a foreign substance that should not be present in the product.
Approximately 195,952 cartons are affected. The recall includes the following lot numbers: 5501127A (Exp Apr-25), 5501236A (Exp Apr-25), 5501341A (Exp Jun-25), 5501406A (Exp Jul-25), 5501408A (Exp Aug-25), 5501516A (Exp Sep-25), 5501568A (Exp Oct-25), 5501829A (Exp Mar-26), 5502000A (Exp Jul-26), 5502004A (Exp Aug-26), 5502005A (Exp Aug-26), 5502092A (Exp Oct-26), 5502217A (Exp Dec-26), and 5502262A (Exp Jan-27).
Consumers currently using this product should stop immediately and contact their healthcare provider. Healthcare providers and pharmacists should verify that prescriptions are not being filled with affected lot numbers.
The recalled product
- Product
- TESTOSTERONE (TESTOSTERONE)
- Brand
- TESTOSTERONE
- Manufacturer
- Strides Pharma, Inc.
- Category
- Drug — Hormone / Transdermal
- Hazard
- benzene
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (20)
- Lot #: 5501127A
- 5501236A
- Exp Apr-25
- 5501341A
- Exp Jun-25
- 5501406A
- Exp Jul-25
- 5501408A
- Exp Aug-25
- 5501516A
- Exp Sep-25
- 5501568A
- Exp Oct-25
- 5501829A
- Exp Mar-26
- 5502000A
- Exp Jul-26
- 5502004A
- 5502005A
- Exp Aug-26
UPCs (2)
- 0364380151012
- 0364380152019
Distribution
Distributed nationwide across the United States.
Related recalls
Same brand · TESTOSTERONE
- ModerateTestosterone Gel 1% Recalled Due to Defective Container Side-Seal Allowing Leakage
FDA (Drugs) · 2025-12-10
- HighTestosterone Gel Recalled Nationwide Due to Benzene Contamination
FDA (Drugs) · 2025-04-02
- HighTestosterone Gel Recalled by Teva for Excessive Potency
FDA (Drugs) · 2024-08-28
- ModerateTestosterone Gel Recalled for Out-of-Specification Viscosity
FDA (Drugs) · 2023-12-06
- HighPrescription testosterone gel recalled due to out-of-specification potency
FDA (Drugs) · 2022-08-03
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModerateFDA Recalls Pred Mild Ophthalmic Suspension Due to Failed Stability Specifications
FDA (Drugs) · 2026-06-03
- ModerateNicotine Transdermal System Patches Recalled for Oxidative Impurity Specification Failure
FDA (Drugs) · 2026-06-03
- HighLiraglutide Injection Recalled Due to Particulate Matter in Cartridges
FDA (Drugs) · 2026-05-27
- LowPrimidone Tablets Recalled for Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27